Beta Bionics, Inc. - Common Stock (NQ:BBNX)

15.24 -0.66 (-4.15%)

Delayed Quote Updated: 1:39 PM EST, Nov 3, 2026 Add to My Watchlist

Price and Volume

Volume	204,932
Open	15.85
Bid (Size)	15.23 (100)
Ask (Size)	15.29 (100)
Prev. Close	15.90
Today's Range	15.18 - 16.06
52wk Range	8.800 - 32.71
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

SueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of November 3, 2026 in Beta Bionics, Inc. Lawsuit - BBNX

Today 10:11 EST

The lawsuit contends Beta Bionics abandoned a built-in safety net for the iLet dosing algorithm and left more than 18,000 customer complaints uninvestigated, alleged operational failures that reached...

From SueWallSt

Via GlobeNewswire

CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds Beta Bionics (NASDAQ: BBNX) Investors of Securities Class Action Lawsuit Deadline on November 3, 2026

Today 9:56 EST

From Faruqi & Faruqi, LLP

Via Business Wire

Performance

52-Week Range 53.4% below 52-week high

15.24

8.8052W Low 32.7152W High

1 Week 31.6% below 1-week high

15.871W Low 22.291W High

Beta Bionics, Inc. - Common Stock (BBNX) traded between $8.80 and $32.71 over the past 52 weeks and last traded at $15.24, 53.4% below its 52-week high. Over the past week it ranged between $15.87 and $22.29.

Past 12 Months

-28.8%

-19.6%

+14.2%

+49.1%

-47.9%

-45.0%

1W -$6.15

1M -$3.71

3M +$1.89

6M +$5.02

YTD -$14.01

1Y -$12.46

BBNX was -45.0% over the past year, +49.1% over six months, -47.9% year to date, -28.8% in the last week.

12 Months vs Market

BBNX

-45.0%

DIA

+9.4%

SPY

+10.7%

QQQ

+8.8%

IWM

+14.6%

Over the past 12 months BBNX returned -45.0% versus DIA (Dow) +9.4%, SPY (S&P 500) +10.7%, QQQ (Nasdaq 100) +8.8% and IWM (Russell 2000) +14.6%.

Volume & Liquidity 0.15× 3-mo avg

Today 204,932 3-mo avg 1.3M

1.5M

1.2M

1.3M

1.2M

YTD

1.2M

1.1M

BBNX most recently traded 204,932 shares against a 3-month average daily volume of 1.3M.

More News

Beta Bionics Announces Participation at Upcoming Investor Conferences

Today 7:30 EST

From Beta Bionics, Inc.

Via GlobeNewswire

Beta Bionics (NASDAQ:BBNX) Slides After Q3 Results as Guidance and Product Timing Weigh ↗

October 27, 2026

Via Chartmill

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Beta Bionics (NASDAQ: BBNX) Investors of Securities Class Action Lawsuit Deadline on November 3, 2026

November 02, 2026

From Faruqi & Faruqi LLP

Via GlobeNewswire

Kaplan Fox Reminds Beta Bionics, Inc. (NASDAQ: BBNX) Investors of an Approaching Securities Class Action Deadline on November 3, 2026

November 02, 2026

From Kaplan Fox & Kilsheimer, LLP

Via GlobeNewswire

Levi & Korsinsky Reminds Beta Bionics, Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of November 3, 2026 - BBNX

November 02, 2026

From Levi & Korsinsky, LLP

Via GlobeNewswire

BBNX Investor Alert: Schall, Brown & Schwartz LLP Files Class Action Lawsuit Against Beta Bionics, Inc. and Announces Opportunity for Investors to Lead Class Action Lawsuit

November 02, 2026

From Schall, Brown & Schwartz LLP

Via GlobeNewswire

BBNX DEADLINE TUESDAY: Bragar Eagel & Squire, P.C. Reminds Beta Bionics, Inc. Investors They Have Until November 3rd to Seek Lead Plaintiff Role with the Firm

October 31, 2026

From Bragar Eagel & Squire

Via GlobeNewswire

Beta Bionics 96 Hour Deadline Alert: Kahn Swick & Foti, LLC Reminds Investors With Losses In Excess Of $100,000 of Deadline in Class Action Lawsuit Against Beta Bionics, Inc. - BBNX

October 30, 2026

From Kahn Swick & Foti, LLC

Via Business Wire

Kaplan Fox Alerts Investors of Beta Bionics, Inc. (NASDAQ: BBNX) to an Upcoming Deadline of November 3, 2026 in the Securities Class Action

October 30, 2026

From Kaplan Fox & Kilsheimer, LLP

Via GlobeNewswire

BBNX UPCOMING DEADLINE: Levi & Korsinsky Alerts Beta Bionics, Inc. Stockholders of Securities Class Action - Contact the Firm

October 30, 2026

From Levi & Korsinsky, LLP

Via ACCESS Newswire

Beta Bionics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Beta Bionics, Inc. - BBNX

October 29, 2026

From SkyMedia, LLC

Via GlobeNewswire

Kaplan Fox Alerts Beta Bionics, Inc. (NASDAQ: BBNX) Investors of Substantial Losses to a Securities Class Action - Critical Deadline is November 3, 2026

October 29, 2026

Via NewMediaWire

BBNX Investor Alert: Schall, Brown & Schwartz LLP Files Class Action Lawsuit Against Beta Bionics, Inc. and Announces Opportunity for Investors to Lead Class Action Lawsuit

October 29, 2026

From Schall, Brown & Schwartz LLP

Via GlobeNewswire

Kaplan Fox Notifies Beta Bionics, Inc. (NASDAQ: BBNX) Investors of a Securities Class Action Lawsuit – Deadline is November 3, 2026

October 28, 2026

From Kaplan Fox & Kilsheimer, LLP

Via GlobeNewswire

BETA BIONICS, INC. INVESTORS WITH LOSSES HAVE UNTIL NOVEMBER 3, 2026 TO JOIN SECURITIES CLASS ACTION – Bernstein Liebhard LLP Announces Deadline

October 28, 2026

From Bernstein Liebhard LLP

Via GlobeNewswire

Beta Bionics (BBNX) Q3 2026 Earnings Call Transcript ↗

October 28, 2026

Via The Motley Fool

Beta Bionics, Inc. Notice of November 3, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

October 27, 2026

From Kahn Swick & Foti, LLC

Via GlobeNewswire

Beta Bionics Q3 Earnings Call Highlights ↗

October 27, 2026

Via MarketBeat

After-Hours Market Movers for Oct. 27, 2026: Gainers and Losers ↗

October 27, 2026

Via Chartmill

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Beta Bionics, Inc. of Class Action Lawsuit and Upcoming Deadlines – BBNX

October 27, 2026

From Pomerantz LLP

Via GlobeNewswire

Beta Bionics Announces Third Quarter 2026 Financial Results and Updates Full Year 2026 Guidance

October 27, 2026

From Beta Bionics, Inc.

Via GlobeNewswire

Bragar Eagel & Squire, P.C. Reminds Beta Bionics, Inc. Investors They Have Until November 3rd to Seek Lead Plaintiff Role with The Firm

October 27, 2026

From Bragar Eagel & Squire

Via GlobeNewswire

Kaplan Fox Notifies Beta Bionics, Inc. (NASDAQ: BBNX) Investors of a Pending Securities Class Action Deadline on November 3, 2026

October 27, 2026

Via NewMediaWire

Frequently Asked Questions

Is Beta Bionics, Inc. - Common Stock publicly traded?

Yes, Beta Bionics, Inc. - Common Stock is publicly traded.

What exchange does Beta Bionics, Inc. - Common Stock trade on?

Beta Bionics, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Beta Bionics, Inc. - Common Stock?

The ticker symbol for Beta Bionics, Inc. - Common Stock is BBNX on the Nasdaq Stock Market

What is the current price of Beta Bionics, Inc. - Common Stock?

The current price of Beta Bionics, Inc. - Common Stock is 15.24

When was Beta Bionics, Inc. - Common Stock last traded?

The last trade of Beta Bionics, Inc. - Common Stock was at 11/03/26 01:39 PM ET

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.